• Synaptic plasticity between primary nociceptors and second order dorsal horn neurons serves key roles in pain and analgesia • A contribution of NMDA receptors to long-term potentiation and long-term depression at these synapses has been demonstrated before, but much less is known about a possible role of endocannabinoids and cannabinoid (CB) 1 receptors.
Introduction
Changes in the efficacy of synaptic transmission between primary nociceptive fibres, which convey information about potentially painful stimuli from the periphery of the body to the CNS, and intrinsic dorsal horn neurons play key roles in the generation of persistent pain states and as mechanisms of analgesic drug actions. Transient reductions in synaptic strength contribute to analgesia evoked by centrally acting drugs such as morphine. Longer lasting changes in synaptic efficacy occur in response to intense or prolonged activation of different classes of primary nociceptors. Intense input from nociceptive C fibres to the spinal dorsal horn induces LTP at the synapses between C fibres and certain types of projection neurons in the superficial spinal dorsal horn (Randic et al. 1993; Ikeda et al. 2003 Ikeda et al. , 2006 . Many lines of evidence indicate that this LTP makes an important contribution to persistent pain states following inflammation or tissue trauma (Ikeda et al. 2006 ). Conversely, LTD, which has been reported to occur mainly at Aδ fibre synapses (Sandkühler et al. 1997) , is a candidate mechanism of analgesia evoked by conditioning nerve stimulation. While the role of NMDA receptors in these plastic changes has been investigated extensively, little is known about potential NMDA receptor-independent plasticity at spinal nociceptor synapses.
Plenty of evidence indicates that CB 1 receptors and endocannabinoids mediate at least some forms of NMDA receptor-independent plasticity in many CNS areas. CB 1 receptors and endocannabinoids have particularly been implicated in short-term and long-term depression (STD and LTD) of synaptic transmission (for reviews see Chevaleyre et al. 2006; Heifets & Castillo, 2009; Kano et al. 2009 ). Both forms require the postsynaptic production of endocannabinoids, mainly of 2-arachidonoyl glycerol (2-AG), that act as retrograde messengers to activate presynaptic CB 1 receptors and to subsequently inhibit transmitter release. Recent evidence suggests that such retrograde synaptic signalling depends on diacylglycerol lipase-α (DGL-α) (Tanimura et al. 2010) , which is the rate-limiting enzyme of 2-AG production in the CNS (Bisogno et al. 2003) . Typical triggers of DGL-α activation are intracellular Ca 2+ rises and activation of postsynaptic group I metabotropic glutamate receptors (mGluR1/5) or of other G q/11 coupled G protein-coupled receptors (GPCRs) (Katona & Freund, 2012) . Increases in intracellular free Ca 2+ concentrations evoked by prolonged depolarisation initiate the 2-AG production underlying depolarisation-induced suppression of inhibition (DSI) (Ohno-Shosaku et al. 2001; Wilson & Nicoll, 2001) or of excitation (DSE) (Kreitzer & Regehr, 2001; Ohno-Shosaku et al. 2002) , both of which are forms of short-term synaptic plasticity. Glutamate release and subsequent activation of mGluR1/5 receptors stimulate a different 2-AG production pathway, which does not require intracellular Ca 2+ and which is capable of inducing both short-lasting and long-lasting synaptic depression after conditioning stimulation of glutamatergic synapses. The induction of LTD requires probably prolonged activation of CB 1 receptors (Kreitzer & Malenka, 2005) possibly together with concomitant presynaptic activity (Robbe et al. 2002; Chevaleyre & Castillo, 2003; Singla et al. 2007) .
It is tempting to speculate that such signalling pathways also contribute to plasticity at dorsal horn nociceptor synapses. Powerful analgesic effects are observed in response to plant-derived or synthetic cannabinoids in many rodent models of inflammatory and neuropathic pain as well as in some clinical trials (Walker & Hohmann, 2005; Lever & Rice, 2006; Pacher et al. 2006) . Compelling evidence supports a contribution of endocannabinoids to intrinsic pain control (Lewis et al. 1980; Meng et al. 1998; Hohmann et al. 2005; Agarwal et al. 2007; Petrosino et al. 2007 ). Most of these actions occur through CB 1 receptors at different levels of the neuraxis including the spinal dorsal horn (Cravatt & Lichtman, 2004) . At this site, CB 1 receptors are densely expressed on the terminals of primary nociceptors (Liang et al. 2004; Hegyi et al. 2009 ), while the opposing postsynaptic structures contain large amounts of DGL-α ). Collectively, these findings indicate that the major molecular prerequisites for endocannabinoid-dependent plasticity are present at C 2012 The Authors. The Journal of Physiology C 2012 The Physiological Society ) at Universitaet Zuerich on October 22, 2012 jp.physoc.org Downloaded from J Physiol ( spinal nociceptor synapses. We now report that presynaptic CB 1 receptors expressed on the spinal terminals of primary nociceptors mediate a previously unidentified form of LTD in primary nociceptor synapses, which exists in parallel to well-known NMDA receptor-dependent LTD. We further provide evidence that primary nociceptor CB 1 receptors serve an additional function by hindering the induction of LTP at spinal nociceptor synapses.
Methods

Animals
Mice lacking CB 1 receptors either globally (CB 1 −/− ; genetic background C57BL/6N; Marsicano et al. 2002) or specifically in primary nociceptors (sns-CB 1 −/− mice; mixed genetic background C57BL/6J × C57BL/6N; Agarwal et al. 2007 ) and their respective littermates were investigated in electrophysiological and morphological experiments. sns-CB 1 −/− mice were generated by crossing CB 1 fl/fl mice (Marsicano et al. 2003) with bacterial artificial chromosome (BAC) transgenic sns-cre mice expressing the cre recombinase under the transcriptional control of the sns (Na v 1.8) gene, which enables gene recombination specifically in primary nociceptors (Agarwal et al. 2004) . The killing of the mice for preparation of sections for morphology or electrophysiology was carried out in accordance with the regulations of the animal welfare committee of the canton of Zurich, and conform to the principles of UK regulations, as described in Drummond (2009) .
Morphology
For immunohistochemistry, adult CB 1 fl/fl and sns-CB 1 −/− littermates (three of each genotype) were deeply anaesthetised with a mixture of ketamine-xylazine injected intraperitoneally and perfused transcardially with 0.9% NaCl for 2 min followed by 100 ml fixative containing 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB; pH 7.4) for 20 min. After perfusion, the spinal cord was immediately isolated, postfixed in 4% PFA for 2 h and washed in 0.1 M PB. Transverse sections 50 μm thick at the lumbar level were cut using a vibratome (Leica, VTS-1000). For immunofluorescence staining, free-floating spinal cord sections were first extensively washed in 0.1 M PB. Following washing in 0.05 M Tris-buffered saline (TBS; pH 7.4) containing 0.3% Triton X-100, the sections were blocked in 10% normal donkey serum (Vector Laboratories, Burlingame, CA, USA) for 45 min. Sections were then incubated in a mixture of polyclonal affinity-purified guinea pig anti-CB 1 (1:200; Fukudome et al. 2004 ; generously provided by Dr Masahiko Watanabe, Hokkaido), rat anti-substance P (SP) (1:250, AbD Serotec) and rabbit anti-calcitonin gene-related peptide (CGRP) antibodies (1:40,000, Baffi et al. 1992; or 1:1000, Calbiochem) in TBS at 4
• C for 48 h. After multiple washings in TBS, the sections were treated with the mixture of Dylight-594-labelled donkey anti-guinea pig, Dylight-488-labelled donkey anti-rat and DyLight-649-conjugated donkey anti-rabbit fluorescent secondary antibodies (1:400; Jackson ImmunoResearch) at room temperature for 2 h in the dark. After extensive washing in TBS and PB, sections were mounted onto glass slides, covered in Vectashield (Vector Laboratories). Coverslips were sealed with nail polish.
Image acquisition was performed on a Nikon A1R confocal laser-scanning system built on a Ti-E inverted Nikon microscope in a sequential acquisition mode, using a 1.4 NA 60× CFI Plan Apochromat VC (Nikon) oil-immersion objective and NIS elements (Nikon) software. Confocal settings (confocal aperture, laser power, gain, offset, pixel dwell and pixel size) were identical for all scans. Optical sections were acquired at a z-separation of 200 nm. For restoration of 3D image stacks, Huygens deconvolution software (Scientific Volume Imaging) was used.
Co-localization of CB 1 immunoreactivity with markers for nociceptive primary afferent terminals was quantified by an experimenter blind to the genotypes, and performed manually on single optical sections taken from the same focal depth of the samples (2 μm from the upper surface of the sections) using Adobe Photoshop CS5. Boutons immunopositive for both SP and CGRP were selected randomly in laminae I and II of the superficial dorsal horn (100 SP + /CGRP + boutons per animal). The number of SP + /CGRP + axon terminals containing CB 1 immunoreactive puncta per number of all SP + /CGRP + boutons ratio was calculated for each animal.
Electrophysiology
Mice 12-28 days old of either sex were decapitated under isoflurane anaesthesia. Laminectomy was performed to prepare lumbar spinal cords with dorsal roots attached. The isolated lumbar spinal cords were glued onto a gelatine block with cyanolyt and cut into 300-to 450-μm-thick transverse slices. Slices were kept in oxygenated (95% O 2 -5% CO 2 ) artificial cerebrospinal fluid containing (in mM): 120 NaCl, 5 Hepes, 26 NaHCO 3 , 1.25 NaH 2 PO 4 , 2.5 KCl, 2 CaCl 2 , 1 MgCl 2 and 10 glucose (pH 7.35) at 35
• C (for details see Ahmadi et al. 2002) .
Slices were transferred to a recording chamber and continuously superfused with extracellular solution (for composition see above) equilibrated with 95% O 2 -5% CO 2 at a flow rate of 1-2 ml min −1 . Neurons in the superficial dorsal horn (lamina I and II, ≤150 μm from the J Physiol 590.19 dorsal margin) were visually identified using the infrared gradient contrast technique coupled to a video microscopy system (Dodt & Zieglgänsberger, 1994) . Whole-cell patch-clamp recordings were performed at room temperature with borosilicate glass recording pipettes (resistance 4-6 M ) filled with intracellular solution containing (in mM) 135 CsF, 5 CsCl, 5 EGTA, 10 Na-Hepes, 1 Mg-ATP, 0.1 Na-GTP and 2 QX-314 (305 mosmol l −1 , pH 7.35, adjusted with CsOH) using a HEKA EPC 10 amplifier controlled with PatchMaster (HEKA electronics) acquisition software. The partial substitution of Cl (pulse duration 100-500 μs, voltage 1-70 V) using bipolar tungsten or suction electrodes. In the experiments on pharmacologically induced LTD (Fig. 4 and 5) and on NMDA receptor-mediated EPSCs, the internal solution contained (in mM): 130 potassium gluconate, 20 KCl, 2 MgCl 2 , 0.05 EGTA, 3 Na-ATP, 0.1 Na-GTP, 10 Na-Hepes and 5 QX-314 (305 mosmol l −1 , pH 7.35 adjusted with KOH). In these experiments, GABAergic and glycinergic synaptic currents were blocked with bicuculline (10 μM) and strychnine (0.5 μM). NMDA receptor-mediated EPSCs were recorded in the presence of strychnine (0.5 μM), bicuculline (10 μM) and NBQX (10 μM), at a holding potential of −30 mV to partially relieve the NMDA receptors from block by extracellular Mg 2+ . In all preincubation experiments (i.e. in the experiments on NMDA-EPSC and in the experiments shown in Figs 3 and 7) antagonists were added immediately after reaching the whole-cell configuration and thus about 10-15 min prior to the conditioning low-frequency stimulation. All electrical signals were sampled at 5 kHz and filtered off-line at 2.9 kHz. Data were analysed using the FitMaster software (HEKA electronics). Input and access resistance of each neuron were continuously monitored by delivering short (20 ms) hyperpolarising voltage steps (to −5 or −10 mV) between the synaptic stimulations. Drug containing solutions were applied via perfusion of the recording chamber. All recordings were carried out at room temperature.
Drugs and chemicals
(-)-Bicuculline methochloride, strychnine hydrochloride and D(−)-2-amino-5-phosphonopentanoic acid (APV) were dissolved in extracellular solution. Stock solutions of WIN 55-212-2 mesylate, AM 251 and CP 55,940 were prepared in DMSO and stored at −20
• C. The DMSO concentration in the superfusate was ≤0.1%. All chemicals were purchased from Tocris.
Data analysis and statistics
For statistical analyses of LTD, average EPSCs were calculated from 10 consecutive current traces evoked during control conditions (i.e. before conditioning stimulation or before drug application), and when a steady-state effect was reached (typically 15 min after conditioning stimulation or 5 min after drug application). Statistical significance was analysed using ANOVA followed by appropriate post hoc tests or, in the case of pair-wise comparisons, with the paired Student's t test. For the comparison of the level of co-localization in CB 1 fl/fl and sns-CB 1 −/− mice, a χ 2 test was used. All statistical analyses were made using SPSS Statistics 17.0.
Results
Low-frequency primary afferent stimulation paired with postsynaptic depolarisation induces LTD at dorsal horn nociceptor synapses
In a first set of experiments, we employed different conditioning stimulation protocols that are known to stimulate synaptic endocannabinoid production and to induce CB 1 receptor-dependent plasticity in other parts of the CNS. We recorded high-threshold primary afferent-evoked EPSCs from lamina II dorsal horn neurons. Synaptic transmission was evoked by electrical stimulation of the afferent dorsal root at a frequency of 3 min −1 . To identify such high-threshold EPSCs, the intensity of dorsal root stimulation was continuously increased from 1 V until a constant latency EPSC was reliably evoked. This was typically achieved with stimulation intensities 15-30% higher than the threshold intensity. EPSCs with activation thresholds ≥15 V were classified as high threshold and were selected for further investigation. To test whether primary nociceptor synapses exhibit DSE, we depolarised the recorded neuron to 0 mV for 3 s. Only 1 out of 15 cells exhibited a significant depression (by 23%). On average, the mean of the first three EPSC amplitudes following the conditioning depolarisation was 107.8 ± 7.3% (mean ± SEM) of the preconditioning value (n = 15, P = 0.59, paired Student's t test) (Fig. 1A) .
In several brain areas, release of endocannabinoids induces LTD of excitatory synaptic transmission. In the spinal dorsal horn, LTD of synapses between primary afferent nociceptors and second order neurons can be elicited by brief high-frequency stimulation (Randic et al. 1993) or by prolonged (15 min) low-frequency synaptic stimulation (Sandkühler et al. 1997) . In our experiments, we applied a short low-frequency stimulation protocol consisting of 200 pulses applied at a frequency of 1.4 Hz, which was chosen because both Aδ and C fibre nociceptors can sustain prolonged firing at this frequency C 2012 The Authors. The Journal of Physiology C 2012 The Physiological Society (Torsney & MacDermott, 2006 ; see also Ikeda et al. 2006) . This conditioning stimulation produced on average a minor but already statistically significant depression of EPSC amplitudes to 74.0 ± 6.4% (mean ± SEM, n = 8, P = 0.045, paired Student's t test, quantified at 15 min after conditioning stimulation) (Fig. 1B) . We then combined this low-frequency stimulation with postsynaptic depolarisation to facilitate endocannabinoid production and release (Kreitzer & Regehr, 2001; Maejima et al. 2001; Wilson & Nicoll, 2001 ). This paired conditioning stimulation induced a pronounced, robust and long-lasting depression of EPSC amplitudes by at least 20% in 18 out of 20 cells. In the remaining two cells, EPSC amplitudes were reduced by 8.5 and 9.5%. On average, EPSC amplitudes were decreased to 57.5 ± 5.9% at 15 min after the conditioning paired stimulation protocol (n = 20; P < 0.0001 paired Student's t test) and remained depressed for the remaining experiment (Fig. 1C) . We finally tested whether prolonged depolarisation (2.5 min) alone was sufficient to induce LTD. Only 1 out of 6 cells exhibited a transient depression of the EPSC amplitude. On average, this latter conditioning protocol had only a minor and statistically insignificant effect on the EPSC amplitudes (8.8 ± 11.7%, n = 6, P = 0.65, paired Student's t test) (Fig. 1D ).
High-threshold primary afferent LTD in CB 1 receptor-deficient mice
We next determined the contribution of the endocannabinoid system to this primary nociceptor LTD and tested whether LTD evoked by the conditioning paired stimulation protocol was altered in global CB 1 mice. On average, conditioning paired stimulation had virtually no effect on EPSC amplitudes (99.8 ± 15.4% of the preconditioning values, n = 13, P = 0.35, paired Student's t test) in global CB 1 −/− mice ( Fig. 2A and D) , strongly suggesting that CB 1 receptors contribute to LTD at nociceptor synapses. However, the lack of LTD in CB 1 −/− mice could also have been due to secondary changes in synaptic circuits caused by the continuous absence of CB 1 receptors throughout development (Berghuis et al. 2007) . Previous reports have shown that the CB 1 receptors responsible for endocannabinoid-dependent LTD are located presynaptically (for recent reviews see e.g. Chevaleyre et al. 2006; Kano et al. 2009 ). We therefore went on to examine the expression of CB 1 receptors on the presynaptic nociceptor terminals in more detail and then investigated mice lacking CB 1 receptors specifically in nociceptors (sns-CB 1 −/− mice; Agarwal et al. 2007) .
Presynaptic CB 1 receptors in high-threshold primary afferent LTD CB 1 receptors are expressed densely in the superficial dorsal horn, the termination area of primary nociceptors. However, the extent to which they are expressed by primary nociceptors or by intrinsic dorsal horn neurons has not fully been resolved. Previous work has shown that dorsal rhizotomy reduced dorsal horn CB 1 receptor density only marginally (Farquhar-Smith et al. 2000) . We therefore performed triple immunofluorescence confocal microscopy on spinal cord sections stained for CB 1 along with substance P (SP) and calcitonin-gene related peptide (CGRP) to quantify the presence of CB 1 receptors on a subpopulation of peptidergic primary afferent nociceptors. The co-occurrence of the two neuropeptides unequivocally identifies a subpopulation of peptidergic nociceptive primary afferents (Wiesenfeld-Hallin et al. 1984; Lawson et al. 1996) . In the superficial dorsal horn of CB 1 fl/fl mice, on average at least 20% of all SP/CGRP double immunopositive axon terminals coexpressed CB 1 receptors. This coexpression was strongly reduced in sns-CB 1 −/− mice ( Fig. 2B) : the ratio of CB 1 containing SP + /CGRP + axon terminals was 2.5-to 3-fold higher in the CB 1 fl/fl animals than in their sns-CB 1 −/− littermates (19% in CB 1 fl/fl versus 7% in sns-CB 1 −/− ; n = 3 for each genotype). Pair-wise comparison also showed that in all three pairs of mice SP + /CGRP + boutons immunoreactive for CB 1 receptors were significantly more abundant in wild-type animals than in their corresponding sns-CB 1 −/− littermates (P < 0.0001, χ 2 test). As in these mice, cre-mediated gene excision occurs only around birth (Agarwal et al. 2004) , developmental effects should be less likely than in global CB 1 −/− mice. In sns-CB 1 −/− mice, LTD evoked by conditioning paired stimulation was strongly impaired. On average, EPSC amplitudes even increased slightly by 13.6 ± 26.1% (n = 13, P = 0.61, paired Student's t test) ( Fig. 2C and D) . This result not only argues against a developmental deficit as the underlying cause of missing LTD in CB 1 −/− mice but also indicates that the CB 1 receptors relevant for this form of LTD are residing on the presynaptic nociceptors terminals.
CB 1 receptors are required for induction but not for maintenance for endocannabinoid-dependent LTD
In a subsequent series of experiments, we applied our LTD induction protocol in the presence of different concentrations of the CB 1 receptor antagonist AM 251 (5 and 50 μM). AM 251 hindered the induction of LTD (quantified at 15 min) in a dose-dependent manner with a minor (statistically insignificant) reduction in LTD at 5 μM ( EPSC amplitudes from pre-conditioning: −41.7 ± 4.3%, n = 10, versus −46.5 ± 8.3%, n = 11 in the presence of vehicle (DMSO)), but with a significant reduction in LTD at 50 μM ( EPSC amplitude: −15.6 ± 10.2%, n = 8) (Fig. 3A and C) . The use of AM 251 also allowed us to investigate whether CB 1 receptor activation was required for induction of LTD only, or also for its maintenance. When AM 251 (50 μM) was applied 10 min after the conditioning stimulation (i.e. when LTD was fully established) AM 251 had no effect ( EPSC amplitude: −43.9 ± 11.1% versus −41.3 ± 8.9%, n = 5, P = 0.57, paired Student's t test) ( Fig. 3B and C) .
Pharmacological activation of CB 1 receptors induces primary afferent LTD
We then tested whether pharmacological activation of CB 1 receptors could mimic the LTD induced by the paired conditioning protocol. To this end, we investigated the effects of two mixed CB 1 and CB 2 receptor agonists, CP 55,940 and WIN 55,212-2 (both at 3 μM). Both compounds decreased high-threshold primary afferent-evoked EPSCs, by 40.2 ± 5.1% (n = 7, P = 0.008, paired Student's t test) and 35.1 ± 3.6 (n = 8, P = 0.01, paired Student's t test), respectively ( Fig. 4A and D) . As the difference between CP 55,940 and WIN 55,212-2 mediated inhibition was small and statistically insignificant, we pooled both data sets for further analyses. We also compared the effect of CB 1 receptor activation on high-threshold and low-threshold primary afferent evoked EPSCs and plotted the degrees of inhibition by CP 55,940 or WIN 55,212-2 versus the stimulation threshold of the EPSC under study. Significant inhibition was only observed for EPSCs with stimulation thresholds ≥15 V ( EPSC amplitude: −37.9 ± 3.0%, n = 15), whereas EPSCs with thresholds <15 V were virtually insensitive to CP 55,940 and WIN 55,212-2 ( EPSC amplitude: −5.7 ± 2.4%, n = 11) (Fig. 4B-D) .
To ensure that this inhibition occurred through activation of CB 1 receptors, we subsequently analysed the effects of CP 55,940 in 's t test, Fig. 5A ). In sns-CB 1 −/− mice, inhibition by CP 55,940 was also strongly reduced ( EPSC amplitude: −11.6 ± 4.4%, n = 6; P = 0.05; paired Student's t test; Fig. 5B ). Like LTD evoked by the synaptic conditioning protocol, CP 55,940-induced depression of EPSC amplitudes was long-lasting and did not depend on continuous CB 1 receptor activation, as indicated by its resistance to AM 251 (either 5 μM or 50 μM) (Fig. 5C ). EPSC inhibition was 40.2 ± 5.1% before AM 251 versus 40.2 ± 11.8% (n = 7) during AM 251 (5 μM), and 24.1 ± 4.7% versus 30.1 ± 4.0% (n = 5) for AM 251 (50 μM) (for statistical analyses see Fig. 5D ).
Heterogeneity of responses in CB 1
−/− and sns-CB 1 −/− mice A close comparison of the consequences of the conditioning paired stimulation in wild-type mice and in CB 1 receptor-deficient mice reveals not only differences in their average responses but also a much higher variability of post-conditioning EPSC amplitudes in CB 1 −/− and sns-CB 1 −/− mice as compared with wild-type mice (Fig. 6A , compare also Fig. 1C and Fig. 2A and C) . In order to analyse this variability in more detail, we classified the responses of the recorded cells as 'LTD' , if their EPSC amplitudes were reduced by more than 20% after the conditioning protocol, as 'no change' if EPSC amplitudes changed by less than 20%, and as potentiation (POT) if amplitudes increased by >20% (Fig. 6B) . A threshold of 20% was chosen, because the average variability in EPSC amplitudes in control mice was close to 20% (19.3 ± 2.8%, n = 20). In 8 of 13 cells recorded in slices obtained from CB 1 −/− mice, and in 4 of 13 recordings made in slices from sns-CB 1 −/− mice, EPSC amplitudes remained virtually stable with changes ≤20%, suggesting that LTD in these synapses depended largely on CB 1 receptors. However, 3 of the 13 recordings made in cells from CB 1 −/− mice, and 6 of the 13 recordings made from sns-CB 1 −/− mice still exhibited LTD. Furthermore, 2 of 13 recordings made in slices from CB 1 −/− mice and 3 of 13 made in slices and sns-CB 1 −/− mice was significantly different from that in wild-type mice. However, the distributions in CB 1 −/− and sns-CB 1 −/− mice were not significantly different from each other (Fig. 6B , for details of the statistical analyses see figure legend).
One likely factor contributing to this higher variability is the previously described presence of NMDA receptor-dependent LTD in the dorsal horn (Sandkühler et al. 1997; Ikeda et al. 2000) , which would lead to the retention of LTD in a subset of nociceptor synapses of CB 1 −/− and sns-CB 1 −/− mice. A second contribution might come from the heterogeneity of nociceptor types (e.g. Aδ and C fibre nociceptors). We first addressed the latter possibility and plotted the post-conditioning EPSC amplitudes against their stimulation thresholds (Fig. 6C ). This analysis revealed that LTP developed only in those cells from CB 1 −/− and sns-CB 1 −/− mice that had EPSC thresholds ≥50 V. These EPSCs most probably originated from C fibres.
We then performed separate analyses for those cells from CB 1 −/− and sns-CB 1 −/− mice that still developed LTD or LTP. Depression of EPSC amplitudes in these cells was very similar to that obtained in wild-type mice (49.6 ± 5.9%, n = 8, in CB 1 −/− and sns-CB 1 −/− mice, versus 46.2 ± 5.9%, n = 18, in wild-type mice, P = 0.73, unpaired Student's t test) (Fig. 6D) .
Five cells recorded from either global CB 1 −/− or sns-CB 1 −/− mice exhibited a pronounced potentiation (by at least 90%) of their EPSC amplitudes following the conditioning paired stimulation protocol. In these cells, EPSC amplitudes showed a progressive increase to 245 ± 26% of the preconditioning value, which reached a plateau about 15 min after the conditioning stimulation and then remained stable until the end of the experiment (Fig. 6E) . The time course of this potentiation was very much reminiscent of the NMDA receptor-dependent LTP reported by others at C fibre synapses in the dorsal horn (Ikeda et al. 2003 (Ikeda et al. , 2006 . It should be added here that the paired conditioning stimulation protocol used in the present study did not evoke LTP in any of the 20 neurons studied in untreated slices of wild-type The difference between high-threshold EPCSs (≥15 V) and low-threshold EPSCs (<15 V) was statistically significant (P ≤ 0.0001, unpaired Student's t test), while differences between WIN 55,212-2 and CP 55,940 were small and remained below statistical significance (P = 0.95 and P = 0.34, for low-threshold and high-threshold EPSCs). J Physiol 590.19 mice, despite the fact that the thresholds of the EPSCs recorded in wild-type mice covered a similar voltage range (15-65 V, average: 43 ± 3.2 V, n = 20 (wild-type mice) versus 15-78 V, average 45 ± 3.2, n = 26 (sns-CB 1 and CB 1 −/− mice pooled); P = 0.62, unpaired Student's t test). Ablation of CB 1 receptors from primary nociceptor terminals hence renders their synapses more susceptible to long-lasting facilitation of synaptic transmission. Preventing or limiting the development of LTP might thus be an important function of CB 1 receptors residing on C fibre terminals.
LTD evoked in the presence of NMDA receptor blockers
As shown in Fig. 6D , a subset of neurons from CB 1 −/− and sns-CB 1 −/− still exhibited pronounced LTD. It has previously been reported that primary nociceptor (Aδ fibre) LTD is partially blocked by the NMDA receptor antagonist APV (Sandkühler et al. 1997; Ikeda et al. 2000) . We therefore tested our paired conditioning protocol also in slices obtained from wild-type mice with NMDA receptors blocked. The responses obtained in the presence of APV (50 μM) were again more variable than those under control conditions ( Fig. 7A and B) . In 6 out of 14 cells, EPSC amplitudes remained virtually constant (97 ± 5.4%) (Fig. 7B and C) . However, six cells exhibited NMDA receptor-independent LTD of >20%. The degree of this LTD was very similar to that measured in untreated wild-type slices (52.6 ± 9.2% (n = 6) versus 53.7 ± 5.9% (n = 18), in the presence of APV versus control conditions) (Fig. 7D) . It should be added that we also observed a potentiation of EPSC amplitudes in two cells pretreated with APV (Fig. 7E) . In these cells, potentiation reached about 400% and 600% of the Fig. 4A . AM 251 was applied after inhibition by CP 55,940 had been established. * * * P ≤ 0.001; * P ≤ 0.05 significantly different from wild-type, ANOVA followed by Dunnett's post hoc test.
preconditioning EPSC amplitude. This potentiation showed kinetic properties distinct from the LTP seen in CB 1 −/− and sns-CB 1 −/− mice, with an almost immediate onset after conditioning stimulation and relatively fast recovery to baseline amplitudes within about 30 min. Finally, we analysed again whether NMDA receptor-independent and presumed CB 1 receptor-dependent synaptic plasticity correlated with the activation threshold of the EPSCs. As shown in Fig. 7F , LTD was observed across the whole range of stimulation thresholds (30-60 V), whereas the two cells that responded with pronounced potentiation had EPSC thresholds >50 V.
These results strongly suggest that NMDA receptordependent and CB 1 receptor-dependent LTD exist in nociceptor synapses as distinct forms of synaptic plasticity. One might, however, argue that genetic ablation or blockade of CB 1 receptors could interfere with NMDA receptor function. We therefore verified that NMDA receptor-mediated EPSCs were not altered in CB 1 −/− mice. Neither amplitudes (130.2 ± 13.4 pA, n = 10, versus 170.9 ± 39.8 pA, n = 7, P = 0.28, unpaired Student's t test) nor decay kinetics (108.6 ± 23.6 ms, n = 10, versus 74.0 ± 16.0, n = 7, P = 0.29) were significantly different between wild-type and CB 1 −/− mice.
Discussion
In the present study, we investigated CB 1 receptordependent plasticity at spinal nociceptor synapses. A moderate depression of synaptic transmission was evoked when low-frequency (1.4 Hz) presynaptic stimulation was applied for 2 to 3 min, and a much more pronounced inhibition was obtained when synaptic stimulation was paired with postsynaptic depolarisation. LTD of high-threshold, presumed nociceptive, input to the dorsal horn has been reported previously (Randic et al. 1993; Sandkühler et al. 1997; Ikeda et al. 2000) . This LTD was partially blocked by the NMDA receptor antagonist APV (Sandkühler et al. 1997 ) and subsequent work showed that, besides NMDA receptors, metabotropic glutamate receptors of the group I and group II families can evoke LTD in these synapses (Chen & Sandkühler, 2000) . However, a contribution of endocannabinoids and CB 1 receptors has not been demonstrated previously. In other areas of the CNS, there is clear evidence that NMDA receptor-dependent and endocannabinoid-dependent LTD exist in parallel (for reviews see Anwyl, 2006; Kano et al. 2009 ). In some cases, such as that of neocortical neurons, NMDA receptors do contribute to endocannabinoid-dependent LTD, but their contribution is presynaptic (Sjostrom et al. 2003; Bender et al. 2006; Nevian & Sakmann, 2006) , while in the case of endocannabinoid-independent LTD, the relevant NMDA receptors are located postsynaptically (Anwyl, 2006) . In the present study, neither genetic ablation of CB 1 receptor nor blockade of NMDA receptors abolished LTD completely. Under both conditions, one fourth to one third of the cells still underwent LTD with no change in the degree of depression as compared with untreated slices from wild-type mice (compare Fig. 1C with Figs  6D and 7D) , suggesting that endocannabinoid-dependent and NMDA receptor-dependent LTD occur independent of each other. Dashed lines designate the range, which was considered as no change (80% ≤ EPSC amplitude ≤ 120%). B, portion of cells showing LTD, no change or a potentiation by more than 20%. * * P < 0.01. Pearson χ 2 (2,32) = 9.23. C-E, time course of normalised EPSC amplitudes in cells that responded to conditioning paired stimulation in the continuous presence of APV either with no change (n = 6) (C), LTD (n = 6) (D) or with a potentiation (n = 2) (E). Insets, averaged traces from 10 consecutively recorded EPSC immediately before (pre, black) and 15 min after (post, red) conditioning stimulation. F, averaged normalised EPSC amplitudes after paired conditioning stimulation plotted against EPSC thresholds.
LTD in Aδ fibre synapses
Previous reports on LTD in the rat dorsal horn showed that it occurs mainly at Aδ fibre synapses (Sandkühler et al. 1997; Ikeda et al. 2000) , while LTP is the typical response of C fibres to ongoing repetitive stimulation (Ikeda et al. 2003 (Ikeda et al. , 2006 ; for a review, see Sandkühler, 2007) . In the present study, we found that pharmacological activation of CB 1 receptors inhibited exclusively EPSCs with a high activation threshold corresponding to Aδ and/or C fibre EPSCs. This is consistent with a previous study by Nyilas et al. (2009) , which provided compelling evidence for the expression of CB 1 receptors on spinal terminals of both Aδ and C fibres. The same study also localised DGL-α to spines opposing dorsal horn nociceptor terminals indicating that primary nociceptor synapses express the molecular machinery required for endocannabinoid-dependent synaptic plasticity. In the present study we extend these findings and provide unambiguous evidence for the presence of CB 1 receptors in peptidergic nociceptors of the superficial dorsal horn. In this context, it is important to note that both SP and CGRP are consistently found not only in C fibres but also in Aδ nociceptors (McCarthy & Lawson, 1989 , 1990 Lawson et al. 1996) . Furthermore, Aδ fibres also strongly express the sns (Na v 1.8) gene (Djouhri et al. 2003) , which was used in the present study to drive cre-mediated deletion of the CB 1 receptor gene in nociceptors. Our finding that the portion of neurons exhibiting LTD was strongly reduced in sns-CB 1 −/− mice is therefore consistent with LTD being mainly expressed in Aδ fibres.
Possible prevention of C fibre LTP by presynaptic CB 1 receptors
The morphological analyses in the present study and in previous studies (Hegyi et al. 2009; Nyilas et al. 2009) indicate that CB 1 receptors are expressed on the presynaptic terminals of nociceptors in lamina II, although only few Aδ fibres terminate in this lamina. These CB 1 receptors most probably reside on C fibre terminals, which extensively innervate lamina II. Our study reveals a possible function also for these receptors. The paired conditioning protocol used in this study did not induce significant potentiation in any of the wild-type neurons recorded. By contrast, LTP was evoked in about 20% of neurons from CB 1 −/− mice and sns-CB 1 −/− mice. All these neurons (5 out of 26) had EPSC thresholds of 50 mV or higher. Their EPSCs should therefore be considered as C fibre EPSCs. CB 1 receptors on the spinal terminals of C fibre nociceptors may thus serve a specific function by hindering the development of LTP in C fibre synapses. Previous work by Wei et al. (2006) has demonstrated that dorsal horn nociceptor synapses can undergo LTP in the presence of intact cannabinoid signalling in response to a similar conditioning protocol (80 synaptic stimulations at 2 Hz paired with depolarization to +30 mV). In their study, GABA A and glycine receptors were blocked with bicuculline and strychnine in the entire spinal cord slice. In our experiments, we partially substituted chloride with fluoride in the internal recording solution in order to interfere with GABAergic and glycinergic inhibition of the recorded neuron only, while otherwise keeping fast synaptic inhibition intact. It is likely that the complete block of GABAergic and glycinergic inhibition greatly increases the level of excitation during the conditioning stimulation and thereby facilitates LTP induction.
Long-term and short-term CB 1 receptor-dependent synaptic plasticity in the dorsal horn
The long-lasting and 'irreversible' inhibition of high-threshold EPSCs described here contrasts to the short-lasting and readily reversible depression of GABAergic and glycinergic synaptic transmission which we described previously in the same preparation (Pernía-Andrade et al. 2009 ). In this previous study, we have shown that GABAergic and glycinergic synapses in the dorsal horn are susceptible to transient DSI and that pharmacological activation of CB 1 receptors or mGluR1/5 elicits a readily reversible reduction in GABAergic and glycinergic synaptic transmission. By contrast, the high-threshold primary afferent EPSCs studied here did not display transient DSE but underwent LTD after conditioning primary afferent stimulation paired with postsynaptic depolarisation. Such distinct forms of endocannabinoid-dependent plasticity have been repeatedly observed in many other CNS areas (for recent reviews see Heifets & Castillo, 2009; Kano et al. 2009) . It is generally accepted that the short-term plasticity involves classical G βγ -mediated inhibition of presynaptic voltage-gated Ca 2+ channels, whereas LTD requires more intense conditioning stimulation, and additional intracellular transduction pathways such as reduced protein kinase A-dependent phosphorylation of the presynaptic scaffolding protein RIM1α (Chevaleyre et al. 2006 (Chevaleyre et al. , 2007 . It is conceivable that the two pathways are also differentially active in inhibitory and excitatory synapses of the spinal dorsal horn.
Recent reports have suggested a role of CB 1 receptors expressed on astrocytes in hippocampal or neocortical synaptic plasticity (Navarrete & Araque, 2010; Han et al. 2012; Min & Nevian, 2012) . In our experiments, such a contribution would have become apparent as a difference in LTD expression between global CB 1 −/− mice, which lack CB 1 receptors from both neurons and glia cells, and sns-CB 1 −/− mice, in which astrocytic CB 1 receptors are retained. Such a difference was not observed.
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Specific inhibition of high-threshold primary afferent EPSCs by CB 1 receptor activation
The present experiments with CP 55,940 and WIN 55,212-2 indicate that only high-threshold but not low-threshold primary afferent synapses are susceptible to CB 1 receptor-dependent inhibition. A similar preferential inhibition of high-threshold primary afferent evoked EPSCs has previously been observed by Liang et al. (2004) . This specificity is unexpected given the fact that virtually all myelinated (low-threshold) primary sensory neurons express CB 1 receptor mRNA and protein (Hohmann & Herkenham, 1999; Agarwal et al. 2007) . A similar discrepancy of expression and functional activity is also found in the case of dorsal horn excitatory interneurons. More than one third of these terminals, identified by the presence of the vesicular glutamate transporter VGluT2 protein, carry CB 1 receptors (Hegyi et al. 2009 ), but their activation does not affect synaptic glutamate release (Pernía-Andrade et al. 2009) , suggesting that these CB 1 receptors are uncoupled from synaptic release control. These receptors may serve functions different from synaptic inhibition or may become coupled to synaptic release only under certain conditions. Implications for spinal nociception and pain plasticity CB 1 receptors and endocannabinoids exert complex effects on dorsal horn sensory processing. Previous work from our group (Pernía-Andrade et al. 2009 ) and from others (Jennings et al. 2001) has shown that activation of CB 1 receptors on inhibitory interneuron terminals evokes a transient and readily reversible inhibition of synaptic GABA and glycine release. This CB 1 receptor-mediated disinhibition contributes to a specific form of secondary hyperalgesia occurring in response to high-intensity C fibre stimulation (Pernía-Andrade et al. 2009 ). In the present study, we show that CB 1 receptor activation does also reduce nociceptive transmission. This action occurs through induction of LTD at spinal nociceptor synapses. Which of these two apparently opposing actions occurring on distinct cellular elements of the dorsal horn circuit dominates may depend on the initial activity of the dorsal horn sensory network. Such state-dependent bidirectional modulation has recently been demonstrated in the rat and mouse cortex, where blockade of CB 1 receptors increased network activity when basal activity was low, but decreased activity in the case of high basal activity (Piet et al. 2011) . In the case of the spinal dorsal horn, similar state-dependent effects could explain the pronociceptive actions of endocannabinoids in the presence of very high nociceptive input, while analgesic actions would predominate at low or moderate activity levels.
Translational aspects
Our results suggest that spinal nociceptor synapses constitute an important site for the analgesic actions of endogenous and exogenous cannabinoids. They may thus have several implications for the discussion about the medicinal use of cannabis in pain patients. First, CB 1 receptor-dependent LTD as well as the LTP preventing actions of dorsal horn CB 1 receptors are likely to make significant contributions to the analgesic actions of cannabinoid receptor agonists in inflammatory or neuropathic pain states. These findings may be taken as support for the medical use of cannabinoids; it should, however, be kept in mind that the pharmacological targeting of these synapses will require drugs that are capable of penetrating into the CNS and which will probably exert significant psychotropic effects in addition to desired analgesia. Second, the processes described here should also be considered as a possible mechanism of conditioned analgesia, evoked e.g. by transcutaneous electrical nerve stimulation (TENS). TENS is most effective when applied at frequencies below 5 Hz and at intensities that cause mild to moderate nociceptor activation (Claydon et al. 2011) . These conditions resemble quite closely the conditioning stimulation used here to induce cannabinoid-dependent LTD of primary nociceptor synapses. Finally, CB 1 receptor-dependent LTD may constitute a previously unknown mechanism of stress-induced endogenous pain control , which has been suggested to depend at least partially on spinal endocannabinoid production ). In summary, we are confident that the findings presented in this report will foster a rational debate on the use of cannabinoid receptor agonists, including medicinal marijuana, in pain patients.
